FOLD251017C00010000 Option on Amicus Therapeutics

An 'Out of The Money' option on Amicus has a strike price that Amicus Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Amicus Therapeutics' 'Out of The Money' options include buying the options if you expect a big move in Amicus Therapeutics' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.

Amicus Therapeutics' Option Greeks for the contract ending on 2025-10-17 at a strike price of 10.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Amicus Therapeutics' option greeks, its implied volatility helps estimate the risk of Amicus Therapeutics stock implied by the prices of the options on Amicus Therapeutics' stock.

Put options written on Amicus Therapeutics grant holders of the option the right to sell a specified amount of Amicus Therapeutics at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Amicus Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Amicus Therapeutics is like buying insurance aginst Amicus Therapeutics' downside shift.

By selling Amicus Therapeutics' put option, the investors signal their bearish sentiment. A short position in a put option written on Amicus Therapeutics will generally make money when the underlying price is above the strike price. Therefore Amicus Therapeutics' put payoff at expiration depends on where the Amicus Stock price is relative to the put option strike price. The breakeven price of 10.15 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Amicus Therapeutics' price. Finally, at the strike price of 10.0, the payoff chart is constant and positive.

Amicus Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Amicus. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Amicus. It also shows strike prices and maturity days for a Amicus Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amicus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amicus Therapeutics. If investors know Amicus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amicus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Amicus Therapeutics is measured differently than its book value, which is the value of Amicus that is recorded on the company's balance sheet. Investors also form their own opinion of Amicus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Amicus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amicus Therapeutics' market value can be influenced by many factors that don't directly affect Amicus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Amicus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amicus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amicus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.